SLC6A3 and Parkinson disease: The correlations between UA levels and DAT binding are consistent with a recent study performed in 52 newly diagnosed, drug-naïve PD patients, although its correlation coefficients (R2putamen = 0.136; R2caudate = 0.349) were not exactly the same[29].